Inventor · disambiguated record
William F. Kiesman
Also filed as: KIESMAN WILLIAM F · KIESMAN William
10 granted patents·13 pending applications·45 citations·filing 2000–2023
85Inventor score
Files withBIOGEN MA INC8BIOGEN INC4KIESMAN WILLIAM F3FLAGSHIP PIONEERING INNOVATIONS VI LLC2KNOPP BIOSCIENCES LLC2
Top patents by PatentIndex Score
23 records- 0188US6649600B1Adenosine receptor antagonists and methods of making and using the sameBIOGEN INC·Filed 2000·Granted Nov 18, 2003·31 cites·38 claims
- 0283US10208003B2Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compoundsKNOPP BIOSCIENCES LLC·Filed 2016·Granted Feb 19, 2019·3 cites·65 claims
- 0382US9512096B2Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compoundsKNOPP BIOSCIENCES LLC·Filed 2012·Granted Dec 6, 2016·3 cites·53 claims
- 0480US11291642B2Dimethyl fumarate particles and pharmaceutical compositions thereofBIOGEN MA INC·Filed 2016·Granted Apr 5, 2022·2 cites·14 claims
- 0567US11142545B2Synthesis of thiolated oligonucleotides without a capping stepBIOGEN MA INC·Filed 2017·Granted Oct 12, 2021·1 cites·21 claims
- 0667US10421716B2Process for preparing alpha-carboxamide pyrrolidine derivativesCONVERGENCE PHARMACEUTICALS·Filed 2015·Granted Sep 24, 2019·1 cites·26 claims
- 0763US9422226B2Process for preparing high purity and crystalline dimethyl fumarateGUZOWSKI JOHN·Filed 2012·Granted Aug 23, 2016·4 cites·28 claims
- 0862US2022362195A1Dimethyl fumarate particles and pharmaceutical compositions thereofBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 0959US2024167031A1Nucleic acid delivery to the central nervous systemBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 1059US2025179492A1Compositions of modified trems and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Application pending·0 cites
- 1158US2022356154A1Process for preparing alpha-carboxamide pyrrolidine derivativesBIOGEN INC·Filed 2021·Application pending·0 cites
- 1258US2024401047A1Trem compositions and methods of useFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 1357US2022098150A1Novel Crystalline FormsBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 1455US11192856B2Process for preparing alpha-carboxamide pyrrolidine derivativesBIOGEN INC·Filed 2018·Granted Dec 7, 2021·0 cites·19 claims
- 1555US2004067966A1Adenosine receptor antagonists and methods of making and using the sameBIOGEN INC·Filed 2003·Application pending·0 cites
- 1652US7579354B2Adenosine receptor antagonists and methods of making and using the sameKIESMAN WILLIAM F·Filed 2006·Granted Aug 25, 2009·0 cites·39 claims
- 1752US2007015732A1Adenosine receptor antagonists and methods of making and using the sameKIESMAN WILLIAM F·Filed 2006·Application pending·0 cites
- 1850US2023406878A1Oligonucleotides, reagents, and preparation thereofBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 1950US2010063071A1Therapeutic compositions and related methods of useKIESMAN WILLIAM F·Filed 2009·Application pending·0 cites
- 2048US12378276B2Convergent liquid phase syntheses of oligonucleotidesBIOGEN MA INC·Filed 2020·Granted Aug 5, 2025·0 cites·17 claims
- 2148US2020062705A1Novel crystalline formsBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 2248US2010130515A1Polymorphs and solvates of a pharmaceutical and method of makingBIOGEN IDEC INC·Filed 2009·Application pending·0 cites
- 2342US2010173914A1Pharmaceuticals, compositions and methods of making and using the sameCHANG HEXI·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William F. Kiesman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →